Phase 4 N=95 Testing Integrative Smoking Cessation for HIV Patients
Smoking · Smoking Cessation · HIV Infections
Primary: Number of Participants Reporting 7-day Point-prevalence Abstinence — 8; 12; 3; 2 participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=110 Postpartum ASA and NT-proBNP
Blood Pressure
Primary: NT-proBNP Levels at 4-6 Weeks Postpartum — 36.5; 39.5 pg/mL — p=0.49
Phase 4 N=44 Pudendal Enhancement of Enhanced Recovery After Surgery (ERAS) for Reconstructive Surgery (PEERS)
Pain Management
Primary: Narcotic Use — 8; 6.75 MME
Phase 4 N=50 ECMO Hemostatic Transfusions in Children
Extracorporeal Membrane Oxygenation Complication · Hemorrhage · Thromboembolism
Primary: Total Platelet Transfusion Dose — 7.4; 0 mL/kg/day
Phase 4 N=33 Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease Patients
Hyperkalemia · End Stage Renal Disease
Primary: Total Number of Episodes of Serum Potassium ≥ 5.5 mEq/L — 13; 41 episodes — p=0.024
Phase 4 N=22 Desogestrel-containing COCP Pharmacokinetic Validation Study
Contraception
Primary: Serum Etonogestrel Concentrations — 0.92 correlation coefficient (r)
Phase 4 N=16 An Open-label Extension to Assess the Continued Efficacy of Omacor Plus Simvastatin
Dyslipidemias
Primary: Median % Change in Non-HDL-C From Baseline to Week 6 — -51.0; -40.8; -34.9 Median percent change from baseline — p=0.0008
Phase 4 N=35 Effect of Post-Operative Anesthetics on Post-Operative Pain in Patients Receiving Endodontic Treatment
Endodontic Disease · Post Operative Pain · Symptomatic Irreversible Pulpitis
Primary: Post-operative Pain Level 6 Hours on a Visual Analog Scale — 64.2; 43.1 units on a scale
Phase 4 N=2 Effect of Tetrabenazine on Stroop Interference in HD
Huntington Disease
Primary: Change in Stroop Interference Score — -1.97; -1 score on a scale
Phase 4 N=87 The No One Waits Study: Acceptability and Feasibility of Community-based Point-of-diagnosis HCV Treatment Study
Hepatitis C, Chronic
Primary: Sustained Virologic Response at 12-weeks (SVR-12) — 58; 58 Participants
Phase 4 N=39 Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder
Schizophrenia · Schizoaffective Disorder · Substance Use Disorders
Primary: Timeline Follow Back (TLFB) — -1.765; -.532 score on a scale
Phase 4 N=1,025 Evaluate the Utility of Serum Hepcidin Levels to Predict Response to Oral or IV Iron
Iron Deficiency Anemia (IDA)
Primary: Multidimensional Assessment of Fatigue (MAF) Scores — -8.8; -8.1 units on a scale
Phase 4 N=15 Healing Ointment Usage Post-surgical Procedure
Surgical Wound
Primary: Objective Erythema Assessment Using Clinical Grading Analog Scale — 0.8; 0.83; 0.75; 0.29 score on a scale
Phase 4 N=70 A Study Evaluating B Cell Levels In Infants Potentially Exposed To Ocrelizumab During Pregnancy
Multiple Sclerosis · Clinically Isolated Syndrome
Primary: Percentage of Infants With B Cell Levels (Cluster of Differentiation 19 [CD19+] Cells) Below the Lower Limit of Normal (LLN) — 0 percentage of participants
Phase 4 N=30 Continuous Double Ovarian Stimulation.
Fertility Issues
Primary: Total Number of Retrieved Oocytes — 13.33; 11.87 oocytes